From Efficacy to Effectiveness: Facilitators and Barriers to PrEP Acceptability and Motivations for Adherence Among MSM and Transgender Women in New York City

Overview

Journal AIDS Patient Care STDS

Specialty Infectious Diseases

Date 2013 Apr 10

PMID 23565928

Citations 223

Authors

Sarit A Golub

Kristi E Gamarel

H Jonathon Rendina

Anthony Surace

Corina L Lelutiu-Weinberger

Affiliations

Soon will be listed here.

Abstract

This study examined potential facilitators and barriers to pre-exposure prophylaxis (PrEP) use and their association with PrEP acceptability and motivations for adherence among 184 MSM and transgender women living in New York City. Participants were presented with educational information about PrEP and completed a computerized survey. Overall, 55.4% of participants reported willingness to take PrEP. The most highly endorsed barriers to PrEP use were health concerns, including both long-term impacts and short-term side effects, questions about PrEP's impact on future drug resistance, and concerns that PrEP does not provide complete protection against HIV. The most highly endorsed facilitator was free access to PrEP, followed by access to support services such as regular HIV testing, sexual health care/monitoring, and access to one-on-one counseling. Participants of color rated both barriers and facilitators as more important than their White counterparts. In multivariate models, barrier and facilitator scores significantly predicted not only PrEP acceptability, but also motivation for PrEP adherence among those who were likely to use PrEP. PrEP implementation programs should consider addressing these barriers and facilitators in protocol and policy development. Findings underscore the importance of support services, such as sexual health counseling, to the success of PrEP as a prevention strategy.

Citing Articles

Assessing awareness and utilisation of pre-exposure prophylaxis for HIV prevention among women who inject drugs in Lagos, Nigeria: a cross-sectional study.

Onigbogi O, Eghaghe O, Onigbogi M, Ojo O, Babalola O BMJ Public Health. 2025; 2(1):e000293.

PMID: 40018130 PMC: 11812754. DOI: 10.1136/bmjph-2023-000293.

Exploring pre-exposure prophylaxis (PrEP) modality preferences among black cisgender women attending family planning clinics in Chicago via a cross-sectional mixed-methods study.

Johnson A, Ott E, Friedman E, Pandiani A, Moore A, Alvarez I BMJ Public Health. 2025; 3(1):e000809.

PMID: 40017987 PMC: 11812854. DOI: 10.1136/bmjph-2023-000809.

Facilitators and Barriers to Pre-Exposure Prophylaxis Uptake Willingness for Full-Service Sex Workers: A Social-Ecological Approach.

Ramos S, Du Bois S Sociol Inq. 2025; 94(4):890-909.

PMID: 39831188 PMC: 11737633. DOI: 10.1111/soin.12589.

Activity Space Mapping and Pre-Exposure Prophylaxis Uptake Among Gay, Bisexual, and Other Sexual Minority Men in Small Cities and Towns in the United States.

Takenaka B, Barbour R, Kirklewski S, Nicholson E, Tengatenga C, Hansen N AIDS Behav. 2025; .

PMID: 39745597 DOI: 10.1007/s10461-024-04601-x.

Facilitators and barriers of HIV pre-exposure prophylaxis use among four key populations in Iran.

Moameri H, Shahrbabaki P, Tavakoli F, Saberi P, Mirzazadeh A, Goudarzi R BMC Health Serv Res. 2024; 24(1):1433.

PMID: 39563358 PMC: 11575091. DOI: 10.1186/s12913-024-11933-w.

References

Thigpen M, Kebaabetswe P, Paxton L, Smith D, Rose C, Segolodi T . Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N Engl J Med. 2012; 367(5):423-34. DOI: 10.1056/NEJMoa1110711. View

Krakower D, Mimiaga M, Rosenberger J, Novak D, Mitty J, White J . Limited Awareness and Low Immediate Uptake of Pre-Exposure Prophylaxis among Men Who Have Sex with Men Using an Internet Social Networking Site. PLoS One. 2012; 7(3):e33119. PMC: 3314648. DOI: 10.1371/journal.pone.0033119. View

Thorburn Bird S, Bogart L . Conspiracy beliefs about HIV/AIDS and birth control among African Americans: implications for the prevention of HIV, other STIs, and unintended pregnancy. J Soc Issues. 2006; 61(1):109-26. DOI: 10.1111/j.0022-4537.2005.00396.x. View

White J, Mimiaga M, Krakower D, Mayer K . Evolution of Massachusetts physician attitudes, knowledge, and experience regarding the use of antiretrovirals for HIV prevention. AIDS Patient Care STDS. 2012; 26(7):395-405. PMC: 3432573. DOI: 10.1089/apc.2012.0030. View

Underhill K, Operario D, Skeer M, Mimiaga M, Mayer K . Packaging PrEP to Prevent HIV: An Integrated Framework to Plan for Pre-Exposure Prophylaxis Implementation in Clinical Practice. J Acquir Immune Defic Syndr. 2011; 55(1):8-13. PMC: 3058525. DOI: 10.1097/qai.0b013e3181e8efe4. View

. Interim guidance: preexposure prophylaxis for the prevention of HIV infection in men who have sex with men. MMWR Morb Mortal Wkly Rep. 2011; 60(3):65-8. View

Guest G, Shattuck D, Johnson L, Akumatey B, Clarke E, Chen P . Acceptability of PrEP for HIV prevention among women at high risk for HIV. J Womens Health (Larchmt). 2010; 19(4):791-8. DOI: 10.1089/jwh.2009.1576. View

Khawcharoenporn T, Kendrick S, Smith K . HIV risk perception and preexposure prophylaxis interest among a heterosexual population visiting a sexually transmitted infection clinic. AIDS Patient Care STDS. 2012; 26(4):222-33. DOI: 10.1089/apc.2011.0202. View

Saberi P, Gamarel K, Neilands T, Comfort M, Sheon N, Darbes L . Ambiguity, ambivalence, and apprehensions of taking HIV-1 pre-exposure prophylaxis among male couples in San Francisco: a mixed methods study. PLoS One. 2012; 7(11):e50061. PMC: 3498189. DOI: 10.1371/journal.pone.0050061. View

10.

Liu A, Kittredge P, Vittinghoff E, Raymond H, Ahrens K, Matheson T . Limited knowledge and use of HIV post- and pre-exposure prophylaxis among gay and bisexual men. J Acquir Immune Defic Syndr. 2008; 47(2):241-7. View

11.

Millett G, Peterson J, Flores S, Hart T, Jeffries 4th W, Wilson P . Comparisons of disparities and risks of HIV infection in black and other men who have sex with men in Canada, UK, and USA: a meta-analysis. Lancet. 2012; 380(9839):341-8. DOI: 10.1016/S0140-6736(12)60899-X. View

12.

Peterson L, Taylor D, Roddy R, Belai G, Phillips P, Nanda K . Tenofovir disoproxil fumarate for prevention of HIV infection in women: a phase 2, double-blind, randomized, placebo-controlled trial. PLoS Clin Trials. 2007; 2(5):e27. PMC: 1876601. DOI: 10.1371/journal.pctr.0020027. View

13.

Nodin N, Carballo-Dieguez A, Ventuneac A, Balan I, Remien R . Knowledge and acceptability of alternative HIV prevention bio-medical products among MSM who bareback. AIDS Care. 2008; 20(1):106-15. DOI: 10.1080/09540120701449096. View

14.

Barash E, Golden M . Awareness and use of HIV pre-exposure prophylaxis among attendees of a seattle gay pride event and sexually transmitted disease clinic. AIDS Patient Care STDS. 2010; 24(11):689-91. DOI: 10.1089/apc.2010.0173. View

15.

Brooks R, Kaplan R, Lieber E, Landovitz R, Lee S, Leibowitz A . Motivators, concerns, and barriers to adoption of preexposure prophylaxis for HIV prevention among gay and bisexual men in HIV-serodiscordant male relationships. AIDS Care. 2011; 23(9):1136-45. PMC: 3244470. DOI: 10.1080/09540121.2011.554528. View

16.

Grant R, Lama J, Anderson P, McMahan V, Liu A, Vargas L . Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010; 363(27):2587-99. PMC: 3079639. DOI: 10.1056/NEJMoa1011205. View

17.

Watson-Jones D, Weiss H, Rusizoka M, Changalucha J, Baisley K, Mugeye K . Effect of herpes simplex suppression on incidence of HIV among women in Tanzania. N Engl J Med. 2008; 358(15):1560-71. PMC: 2643126. DOI: 10.1056/NEJMoa0800260. View

18.

Golub S, Operario D, Gorbach P . Pre-exposure prophylaxis state of the science: empirical analogies for research and implementation. Curr HIV/AIDS Rep. 2010; 7(4):201-9. PMC: 2938422. DOI: 10.1007/s11904-010-0057-1. View

19.

Amico K, McMahan V, Goicochea P, Vargas L, Marcus J, Grant R . Supporting study product use and accuracy in self-report in the iPrEx study: next step counseling and neutral assessment. AIDS Behav. 2012; 16(5):1243-59. DOI: 10.1007/s10461-012-0182-5. View

20.

Mimiaga M, Case P, Johnson C, Safren S, Mayer K . Preexposure antiretroviral prophylaxis attitudes in high-risk Boston area men who report having sex with men: limited knowledge and experience but potential for increased utilization after education. J Acquir Immune Defic Syndr. 2009; 50(1):77-83. PMC: 2659469. DOI: 10.1097/QAI.0b013e31818d5a27. View